Form 4: Ichor Holdings CEO Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Ichor Holdings CEO, Jeff Andreson, exercised stock options and sold shares on November 25, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Jeff Andreson, CEO of Ichor Holdings, exercised options to acquire 36,000 shares at $24.05 and 6,800 shares at $24.89 on November 25, 2024.
- On the same day, Andreson sold 42,800 shares at $34.58.
- These transactions were executed under a pre-existing Rule 10b5-1 trading plan.
- Following these transactions, Andreson directly owns 267,437 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to executive stock transactions. It doesn't indicate any positive or negative sentiment about the company's performance.
Positives
- The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to avoid accusations of insider trading.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially leading to short-term price fluctuations.
Industry Context
This is a routine filing related to executive stock transactions and is common in publicly traded companies. The use of a 10b5-1 plan is a standard practice to manage insider trading risks.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, such as those in the semiconductor equipment industry like Applied Materials and Lam Research.
- These plans allow executives to sell shares without being accused of insider trading, similar to how executives at other tech companies manage their stock holdings.
- The vesting schedules of the options are also typical, with a portion vesting initially and the remainder over a period of time, which is consistent with industry standards for executive compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by the CEO, but the pre-arranged nature of the sale mitigates potential concerns.
Key Dates
| Date | Description |
|---|---|
| 12/06/2018 | 25% of the first option grant vested on this date. |
| 02/15/2019 | 25% of the second option grant vested on this date. |
| 11/25/2024 | Date of the option exercises and share sale. |
| 11/27/2024 | Date the Form 4 was signed. |
Keywords
insider trading, Form 4, stock options, share sale, 10b5-1 plan, Ichor Holdings, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.